Andrew Carr is the Nuffield Professor of Orthopaedic Surgery at the University of Oxford and trained at Bristol, Sheffield, Oxford, Seattle and Melbourne. He established the shoulder surgery service in Oxford and is past President of the British Shoulder and Elbow Surgery Society. He was a Non-Executive Director and then Divisional Director of the Nuffield Orthopaedic Centre during the formation of Oxford University Hospitals NHS Trust. He is currently an elected Council member of the Royal College of Surgeons of England
His research has focussed on the development and evaluation of surgical implants. Whilst working with John Goodfellow, he defined the use of the Oxford Knee as a partial knee replacement which has been implanted in over two million people worldwide. He pioneered the importance of patients’ views in assessing the outcome of surgery and the Oxford Scores, which he co-invented are now used globally to assess patient outcomes and direct health policy. He has improved the infrastructure for clinical trials for orthopaedic surgery in the UK and co-founded the Royal College of Surgeons of England Trial Unit in Oxford in 2012. He has contributed to novel trial designs including the controversial use of placebo surgery controls. His laboratory has invented new surgical implants using electrospun fibres that improve cell growth and tissue healing after surgery.
He is author of over 450 publications, including more than 30 in the Lancet, BMJ and Nature Biotechnology, which have been cited over 44,000 times. He is is one of the 25 most cited surgical researchers globally. His research has featured in the media including the Times, the Guardian, the Daily Telegraph, the Observer, BBC Horizon, BBC news, BBC radio, CBS the Doctors, the New Statesman and Der Spiegel.
He was head of the department of orthopaedics, rheumatology and musculoskeletal sciences from 2001-2022. During his tenure the department grew to become the largest academic musculoskeletal department globally with 600 staff, over 100 postgraduate research students and an external grant portfolio of £180million. He led the development of the Botnar Research Institute which now houses over 300 multidisciplinary researchers. He was Director of the NIHR Biomedical Research Unit in Oxford from 2008-2017 and was instrumental in the relocation of the Kennedy Institute for Rheumatology to Oxford in 2013.
He is a fellow of the Academy of Medical Sciences and an NIHR Senior Investigator. His awards include an honorary Doctorate of Medicine from the University of Copenhagen, the Gold Medal of the British Orthopaedic Association and the Steindler Award from the USA. He is a Nuffield Medical Trustee, Chair of the Nuffield Oxford Hospitals Fund and Deputy Chair of Trustees of the University of Bristol.